The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets

Martina Rossi1, Kotb Abdelmohsen1

  • 1Laboratory of Genetics and Genomics, RNA Regulation Section, National Institute on Aging Intramural Research Program, National Institutes of Health, 251 Bayview Blvd., Baltimore, MD 21224, USA.

Cells
|August 7, 2021
PubMed

Insights

Senotherapeutics offer new ways to combat aging by targeting senescent cells. This review focuses on senolysis, using surface biomarkers to eliminate these cells and treat age-related diseases.

Area of Science:

  • Gerontology and Cellular Biology
  • Biomedical Sciences
  • Molecular Biology

Background:

  • Cellular senescence contributes to age-associated diseases and physiological decline.
  • Senotherapeutics, including senomorphics and senolytics, aim to mitigate these effects.
  • Senolytics target senescent cells for clearance, reducing inflammation and promoting immune removal.

Purpose of the Study:

  • To review current knowledge on senolysis, a strategy to eliminate senescent cells.
  • To highlight novel surface biomarkers of cellular senescence.
  • To discuss the potential of these biomarkers as targets for senotherapeutics.

Main Methods:

  • Literature review of recent research on senolysis and cellular senescence.
  • Focus on identifying and analyzing surface biomarkers specific to senescent cells.
  • Discussion of the therapeutic implications of targeting these biomarkers.

Main Results:

  • Senescent cells exhibit unique surface proteins crucial for their survival.
  • These surface proteins represent promising targets for senolytic drugs.
  • Targeting surface biomarkers can enhance the selective elimination of senescent cells.

Conclusions:

  • Targeting surface biomarkers is a viable senotherapeutic strategy.
  • Further research into these biomarkers could lead to effective treatments for age-related conditions.
  • Senolysis via surface biomarker targeting holds significant promise for improving healthspan.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.7K